A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

Overview of attention for article published in BMC Complementary Medicine and Therapies, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 165,924 followers.

RT @HealthyFellow: A randomized #placebo-controlled phase I clinical trial to evaluate the #immunomodulatory activities of #Atractylodes #l…

RT @HealthyFellow: A randomized #placebo-controlled phase I clinical trial to evaluate the #immunomodulatory activities of #Atractylodes #l…

RT @HealthyFellow: A randomized #placebo-controlled phase I clinical trial to evaluate the #immunomodulatory activities of #Atractylodes #l…

RT @HealthyFellow: A randomized #placebo-controlled phase I clinical trial to evaluate the #immunomodulatory activities of #Atractylodes #l…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.